Jennifer Stevens, Chief Regulatory Officer at TriSalus Life Sciences, Inc. (TLSI), sold 8,704 shares at $5.18 ($45K) on 2025-05-19, disclosed to the SEC on 2025-05-21.
Open-market sale of $45k TLSI by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |